Header Logo

Connection

BIYKEM BOZKURT to Injections, Subcutaneous

Back to Details
This is a "connection" page, showing publications BIYKEM BOZKURT has written about Injections, Subcutaneous.
BIYKEM BOZKURT
Connection Strength
0.058
Injections, Subcutaneous
  1. Survodutide for treatment of obesity: Baseline characteristics of participants in a randomized, double-blind, placebo-controlled, phase 3 trial (SYNCHRONIZE?-1). Diabetes Obes Metab. 2026 Jan; 28(1):337-346.
    View in: PubMed
    Score: 0.058
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.